Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ipsen | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Observational study, retrospective and prospective, of an analytical nature. Data will be collected from medical records and/or through contact with physicians and institutions (secondary data collection). Patients included retrospectively or prospectively will be followed during the data collection period for the evaluation of treatments and survival. No intervention is planned in this protocol.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with pathological diagnosis of renal cell carcinoma | Patients aged 18 years or older, who have been diagnosed with renal cell carcinoma (new case or recurrence) since January 2015 and during the study recruitment period. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Observational study | Other | This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Build a real-life renal cell cancer database in Brazil and Latin America | 2022 |
| Measure | Description | Time Frame |
|---|---|---|
| Sociodemographic characteristics checklist | Describe sociodemographic characteristics: age at diagnosis, race, education, family income, occupation, personal habits, family history, comorbidities, treatment funding (public or private), treatment institution (public, private or philanthropic). | 2022 |
| Clinicopathological characteristics of patients with renal cell cancer checklist |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients aged 18 years or older, who have been diagnosed with renal cell carcinoma (new case or recurrence) since January 2015 and during the study recruitment period.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| André Poisl Fay | Latin American Cooperative Oncology Group | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CINPAM - Centro Integrado de Pesquisa da Amazônia | Manaus | Amazonas | 69.020-030 | Brazil | ||
| Oncocentro Ceará (Rede D'or) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
date of onset of symptoms, pre-treatment symptoms, histology, clinical and pathological stage, performance status, tests used in staging, date of diagnosis, site of metastases, complications clinics. |
| 2022 |
| Characteristics of systemic treatment checklist | date of biopsy; dates, type and lines of drug treatment. | 2022 |
| Time between diagnosis and start of treatment. | Characteristics of systemic treatment checklist | 2022 |
| Causes of delay or discontinuation of each treatment checklist | Characteristics of systemic treatment | 2022 |
| Progression-free survival in each therapeutic line | 2022 |
| Overall survival | 2022 |
| Fortaleza |
| Ceará |
| 60.135-237 |
| Brazil |
| Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO) | Cachoeiro de Itapemirim | Espírito Santo | 29.308-065 | Brazil |
| Santa Casa de Misericórdia de Feira de Santana | Feira de Santana | Estado de Bahia | 44.051-754 | Brazil |
| NOB - Núcleo de Oncologia da Bahia (Oncoclínicas) | Salvador | Estado de Bahia | 40.170-110 | Brazil |
| Onco-Vida Instituto Especializado de Oncologia | Brasília | Federal District | 70.390-700 | Brazil |
| Hospital do Câncer do Maranhão Dr. Tarquínio Lopes Filho | São Luís | Maranhão | 65.015-460 | Brazil |
| Clinica Prognóstica - Centro de Pesquisa Clínica Onconeo | Campo Grande | Mato Grosso do Sul | 79.002-061 | Brazil |
| ICTR - Instituto do Câncer e Transplante de Curitiba | Curitiba | Paraná | 80.510-130 | Brazil |
| Hospital Napoleão Laureano | João Pessoa | Paraíba | 58.013-140 | Brazil |
| Hospital Porto Dias | Belém | Pará | 66.093-032 | Brazil |
| CPO - Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS | Porto Alegre | Rio Grande do Sul | 90.619-900 | Brazil |
| Clínica de Hematologia e Oncologia Viver | Santa Maria | Rio Grande do Sul | 97.015-450 | Brazil |
| CTTB - Centro de Tratamento de Tumores Botafogo (Oncoclínicas) | Rio de Janeiro | 22.250-905 | Brazil |
| Hemomed Instituto de Oncologia e Hematologia | São Paulo | 01.236-030 | Brazil |
| CPO - Centro Paulista de Oncologia (Oncoclínicas) | São Paulo | 04.538-135 | Brazil |
| ID | Term |
|---|---|
| D007680 | Kidney Neoplasms |
| ID | Term |
|---|---|
| D014571 | Urologic Neoplasms |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052801 | Male Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019370 | Observation |
| ID | Term |
|---|---|
| D008722 | Methods |
| D008919 | Investigative Techniques |
Not provided
Not provided